|
1
|
Ozols RF: Update on the management of
ovarian cancer. Cancer J. 8(Suppl 1): S22–S30. 2002.PubMed/NCBI
|
|
2
|
Tummala MK and McGuire WP: Recurrent
ovarian cancer. Clin Clin Adv Hematol Oncol. 3:723–736. 2005.
|
|
3
|
Šale S and Orsulic S: Models of ovarian
cancer metastasis: murine models. Drug Discov Today Dis Models.
3:149–154. 2006.
|
|
4
|
Sallinen H, Anttila M, Narvainen J, et al:
A highly reproducible xenograft model for human ovarian carcinoma
and application of MRI and ultrasound in longitudinal follow-up.
Gynecol Oncol. 103:315–320. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hamilton TC, Young RC, Louie KG, et al:
Characterization of a xenograft model of human ovarian carcinoma
which produces ascites and intraabdominal carcinomatosis in mice.
Cancer Res. 44:5286–5290. 1984.PubMed/NCBI
|
|
6
|
Molpus KL, Koelliker D, Atkins L, et al:
Characterization of a xenograft model of human ovarian carcinoma
which produces intraperitoneal carcinomatosis and metastases in
mice. Int J Cancer. 68:588–595. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takahashi S, Doss C, Levy S and Levy R:
TAPA-1, the target of an antiproliferative antibody, is associated
on the cell surface with the Leu-13 antigen. J Immunol.
145:2207–2213. 1990.PubMed/NCBI
|
|
8
|
Bradbury LE, Kansas GS, Levy S, Evans RL
and Tedder TF: The CD19/CD21 signal transducing complex of human B
lymphocytes includes the target of antiproliferative antibody-1 and
Leu-13 molecules. J Immunol. 149:2841–2850. 1992.PubMed/NCBI
|
|
9
|
Matsumoto AK 1, Martin DR, Carter RH,
Klickstein LB, Ahearn JM and Fearon DT: Functional dissection of
the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J Exp Med.
178:1407–1417. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brass AL, Huang IC, Benita Y, et al: The
IFITM proteins mediate cellular resistance to influenza A H1N1
virus, West Nile virus, and dengue virus. Cell. 139:1243–1254.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smyth GK: Linear models and empirical
Bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:32004.PubMed/NCBI
|
|
12
|
Watts GS, Futscher BW, Holtan N, DeGeest
K, Domann FE and Rose SL: DNA methylation changes in ovarian cancer
are cumulative with disease progression and identify tumor stage.
BMC Med Genomics. 1:472008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
14
|
Yu F, Ng SS, Chow BK, et al: Knockdown of
interferon-induced transmembrane protein 1 (IFITM1) inhibits
proliferation, migration, and invasion of glioma cells. J
Neurooncol. 103:187–195. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang Y, Lee JH, Kim KY, et al: The
interferon-inducible 9–27 gene modulates the susceptibility to
natural killer cells and the invasiveness of gastric cancer cells.
Cancer Lett. 221:191–200. 2005.
|
|
16
|
Lee J, Goh SH, Song N, et al:
Overexpression of IFITM1 has clinicopathologic effects on gastric
cancer and is regulated by an epigenetic mechanism. Am J Pathol.
181:43–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hatano H, Kudo Y, Ogawa I, et al:
IFN-induced transmembrane protein 1 promotes invasion at early
stage of head and neck cancer progression. Clin Cancer Res.
14:6097–6105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: a practical and powerful approach to
multiple testing. J Roy Stat Soc Ser B (Stat Method). 57:289–300.
1995.
|
|
19
|
Naora H and Montell DJ: Ovarian cancer
metastasis: integrating insights from disparate model organisms.
Nat Rev Cancer. 5:355–366. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Howe A, Aplin AE, Alahari SK and Juliano
RL: Integrin signaling and cell growth control. Curr Opin Cell
Biol. 10:220–231. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aplin A, Howe A, Alahari S and Juliano RL:
Signal transduction and signal modulation by cell adhesion
receptors: the role of integrins, cadherins, immunoglobulin-cell
adhesion molecules, and selectins. Pharmacol Rev. 50:197–263.
1998.PubMed/NCBI
|
|
22
|
Choi YP, Kim BG, Gao MQ, Kang S and Cho
NH: Targeting ILK and β4 integrin abrogates the invasive potential
of ovarian cancer. Biochem Biophys Res Commun. 427:642–648.
2012.
|
|
23
|
Cheon DJ, Tong Y, Sim MS, et al: A
collagen-remodeling gene signature regulated by TGFβ signaling is
associated with metastasis and poor survival in serous ovarian
cancer. Clin Cancer Res. 20:711–723. 2014.PubMed/NCBI
|
|
24
|
Scotton CJ, Wilson JL, Milliken D, Stamp G
and Balkwill FR: Epithelial cancer cell migration: a role for
chemokine receptors? Cancer Res. 61:4961–4965. 2001.PubMed/NCBI
|
|
25
|
Salama I 1, Malone PS, Mihaimeed F and
Jones JL: A review of the S100 proteins in cancer. Eur J Surg
Oncol. 34:357–364. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davies BR, O’Donnell M, Durkan GC, et al:
Expression of S100A4 protein is associated with metastasis and
reduced survival in human bladder cancer. J Pathol. 196:292–299.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rudland PS, Platt-Higgins A, Renshaw C, et
al: Prognostic significance of the metastasis-inducing protein
S100A4 (p9Ka) in human breast cancer. Cancer Res. 60:1595–1603.
2000.PubMed/NCBI
|
|
28
|
Ninomiya I, Ohta T, Fushida S, et al:
Increased expression of S100A4 and its prognostic significance in
esophageal squamous cell carcinoma. Int J Oncol. 18:715–720.
2001.PubMed/NCBI
|
|
29
|
Ai KX, Lu LY, Huang XY, Chen W and Zhang
HZ: Prognostic significance of S100A4 and vascular endothelial
growth factor expression in pancreatic cancer. World J
Gastroenterol. 14:1931–1935. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gongoll S, Peters G, Mengel M, et al:
Prognostic significance of calcium-binding protein S100A4 in
colorectal cancer. Gastroenterology. 123:1478–1484. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He JD 1, Luo HL, Li J, Feng WT and Chen
LB: Influences of the interferon induced transmembrane protein 1 on
the proliferation, invasion, and metastasis of the colorectal
cancer SW480 cell lines. Chin Med J. 125:517–522. 2012.PubMed/NCBI
|
